Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Did You Know Previous | All Articles This Week | Next
This article originally posted 02 February, 2010 and appeared in  Issue 507

Approval of Diamyd's Diabetes Vaccine Set for 2011

Approval of Diamyd's Diabetes Vaccine Set for 2011: The diabetes vaccine being developing by Diamyd is not far from being approved. Diamyd is using two different technologies: the first is based on a GAD65 molecule. The molecule was shown to stall the destruction of beta cells connected with Type 1 diabetes. The other technology involves a system to deliver substances directly to nerve cells. A parallel phase III trial will be performed in Europe in 2011.

 
Advertisement
Advertisement

 

Bookmark and Share | Print | Category | Home

This article originally posted 02 February, 2010 and appeared in  Issue 507

Past five issues: Diabetes Clinical Mastery Series Issue 85 | Issue 626 | Special Edition - Getting Patients on Track | Diabetes Clinical Mastery Series Issue 84 | Issue 625 |

 
Diabetes In Control Advertisers
 
 
Cast Your Vote
Now that once-weekly GLP-1 is available, which product are you recommending for your type 2 patients?

Navigate Diabetes In Control

Cardiovascular CE & CME Clinical Slides Drugs Affecting BG Safety Tools Test Your Knowledge Medications Polls Obesity Case Studies Jobs Interviews GLP-1 Agonist Sheri R. Colberg, PhD

Announcement:
 

Free Weekly Newsletter
Sign up here.

Free CE Available
CE Programs on diabetes

Search Articles On Diabetes In Control